| 16521-7 |
Calcium^3rd specimen post XXX challenge |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
16521-7 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium sp3 p chal Ur-sCnc |
|
|
|
Y |
|
After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp3; sp3 p chal; Spec; Substance concentration; UA; UR; Urn |
2.34 |
1.0l |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 16522-5 |
Calcium^4th specimen post XXX challenge |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Calcium [Moles/volume] in Urine --4th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
16522-5 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium sp4 p chal Ur-sCnc |
|
|
|
Y |
|
After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp4; sp4 p chal; Spec; Substance concentration; UA; UR; Urn |
2.34 |
1.0l |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 16523-3 |
Calcium^5M post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
16523-3 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium 5M p chal SerPl-sCnc |
|
|
|
Y |
|
5M p chal; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0l |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 16524-1 |
Calcium^6H post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
16524-1 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium 6h p chal SerPl-sCnc |
|
|
|
Y |
|
6h p chal; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0l |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 16525-8 |
Calcium/Phosphate |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcium/Phosphate [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16525-8 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium/Phosphate SerPl |
|
|
|
Y |
|
Ca; Ca Phos; Cal; CAP; Chemistry; i Phos; Inorganic phosphate; Mass concentration ratio; Mass ratio; MCRto; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 16526-6 |
Calcium/Protein |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcium/Protein [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16526-6 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium/Prot SerPl |
|
|
|
Y |
|
Ca; Cal; Chemistry; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 16527-4 |
Calcium/Sodium |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcium/Sodium [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16527-4 |
|
|
|
|
Observation |
|
|
|
0 |
Calcium/Sodium SerPl |
|
|
|
Y |
|
Ca; Cal; Chemistry; Mass concentration ratio; Mass ratio; MCRto; Na; Na+; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 16528-2 |
Campylobacter coli rRNA |
ACnc |
Ser |
Pt |
Qn |
Probe |
|
ACTIVE |
Campylobacter coli rRNA [Units/volume] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16528-2 |
|
Probe |
|
|
Both |
|
|
|
0 |
C coli rRNA Ser Probe-aCnc |
|
|
|
Y |
|
Arbitrary concentration; C coli; Campy; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; ribosomal RNA; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
In the Short Name 'Prb' was changed to 'Probe' for clarity. |
0 |
| 16529-0 |
Campylobacter jejuni rRNA |
ACnc |
Ser |
Pt |
Qn |
Probe |
|
ACTIVE |
Campylobacter jejuni rRNA [Units/volume] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16529-0 |
|
Probe |
|
|
Both |
|
|
|
0 |
C jejuni rRNA Ser Probe-aCnc |
|
|
|
Y |
|
Arbitrary concentration; C jejuni; Campy; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; ribosomal RNA; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
In the Short Name 'Prb' was changed to 'Probe' for clarity. |
0 |
| 1653-5 |
1-Methylhistidine |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
1-Methylhistidine [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
1653-5 |
|
|
|
|
Observation |
|
|
|
0 |
1Me-hist Ur-mCnc |
|
|
|
Y |
|
1Me-hist; Chemistry; i; Level; Mass concentration; methyl-histidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 16530-8 |
Campylobacter jejuni rRNA |
PrThr |
Ser |
Pt |
Ord |
Probe |
|
ACTIVE |
Campylobacter jejuni rRNA [Presence] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16530-8 |
|
Probe |
|
|
Both |
|
|
|
0 |
C jejuni rRNA Ser Ql Probe |
|
|
|
|
|
C jejuni; Campy; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Serum; SR |
2.63 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. In the Short Name 'Prb' was changed to 'Probe' for clarity. |
0 |
| 16531-6 |
Campylobacter lari rRNA |
ACnc |
Ser |
Pt |
Qn |
Probe |
|
ACTIVE |
Campylobacter lari rRNA [Units/volume] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16531-6 |
|
Probe |
|
|
Both |
|
|
|
0 |
C lari rRNA Ser Probe-aCnc |
|
|
|
Y |
|
Arbitrary concentration; C lari; Campy; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; ribosomal RNA; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 16532-4 |
Campylobacter lari rRNA |
PrThr |
Ser |
Pt |
Ord |
Probe |
|
ACTIVE |
Campylobacter lari rRNA [Presence] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16532-4 |
|
Probe |
|
|
Both |
|
|
|
0 |
C lari rRNA Ser Ql Probe |
|
|
|
|
|
C lari; Campy; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Serum; SR |
2.63 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 16533-2 |
Helicobacter pylori Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Helicobacter pylori Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
16533-2 |
|
|
|
|
Both |
|
|
|
0 |
H pylori Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pylori; Campylobacter pylori; Dilution factor; Dilution Factor (Titer); Gastro; Gastroenterology; GI; H pyl; H pylori; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0l |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 16534-0 |
Campylobacter sp rRNA |
PrThr |
Ser |
Pt |
Ord |
Probe |
|
ACTIVE |
Campylobacter sp rRNA [Presence] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16534-0 |
|
Probe |
|
|
Both |
|
|
|
0 |
Campylobacter rRNA Ser Ql Probe |
|
|
|
|
|
Campy; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Serum; species; spp; SR |
2.63 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 16535-7 |
Canary droppings Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Canary droppings IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
16535-7 |
|
|
|
|
Both |
|
|
|
0 |
Canary Drop IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e200; Feces; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; stool |
2.42 |
1.0l |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 16536-5 |
Canary serum proteins Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Canary serum proteins Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
16536-5 |
|
|
|
|
Both |
|
|
|
0 |
Canary Serum Prot Ab Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e199; Point in time; Protein; QNT; Quan; Quant; Quantitative; Random; Ser; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 16537-3 |
Candida albicans Ab |
ACnc |
Ser |
Pt |
Qn |
Immune diffusion |
|
ACTIVE |
Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16537-3 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
C albicans Ab Ser ID-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C albicans; Cand; Candidiasis; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; m005; m5; Microbiology; Monilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Thrush |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 16538-1 |
Candida sp Ab.IgA |
ACnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16538-1 |
|
|
|
|
Both |
|
|
|
0 |
Candida IgA Sal-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cand; Candidiasis; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Monilia; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; species; spp; Thrush |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 16539-9 |
Candida sp Ag |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Candida sp Ag [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16539-9 |
|
|
|
|
Both |
|
|
|
0 |
Candida Ag Ser Ql |
|
|
|
|
|
Antigen; Antigens; Cand; Candidiasis; ID; Infectious Disease; InfectiousDisease; Microbiology; Monilia; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Thrush |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1654-3 |
1-Naphthalene |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
1-Naphthalene [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
1654-3 |
|
|
|
|
Both |
|
|
|
0 |
1Naphthalene Ur-mCnc |
|
|
|
Y |
|
1Naphthalene; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 16540-7 |
Cannabinoids |
ACnc |
Ser/Plas |
Pt |
Ord |
Confirm |
|
DEPRECATED |
Deprecated Cannabinoids [Presence] in Serum or Plasma by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16540-7 |
|
Confirm |
|
|
|
|
|
|
0 |
Deprecated Cannabinoids SerPl Ql Cfm |
|
|
|
|
|
Addiction; Arbitrary Concentration; Cannabinoid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Marijuana; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; THC |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 16542-3 |
Cannabinoids |
MCnc |
Ser/Plas |
Pt |
Qn |
Confirm |
|
ACTIVE |
Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16542-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Cannabinoids SerPl Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cannabinoid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Marijuana; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; THC |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 16543-1 |
Cannabinoids |
MCnc |
Unk sub |
Pt |
Qn |
Confirm |
|
ACTIVE |
Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16543-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Cannabinoids Usub Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cannabinoid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Marijuana; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; THC; Unknown substance; Usub |
2.36 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 16544-9 |
Canrenone |
ACnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Canrenone [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16544-9 |
|
|
|
|
Both |
|
|
|
0 |
Canrenone Ur-aCnc |
|
|
|
Y |
|
Arbitrary concentration; DRUG/TOXICOLOGY; Drugs; Luvion; Phanurane; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
